Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TGAN
1201
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $20.7M | 0.01% |
3,805,548
-47
| -0% | -$277 |
|
1202
Graphic Packaging
GPK
$3.46B
| $20.7M | 0.01% |
929,930
+67,493
| +8% | +$1.48M |
|
1203
Old Republic International
ORI
$10.4B
| $20.6M | 0.01% |
854,899
+8,368
| +1% | +$196K |
|
1204
BioLife Solutions
BLFS
$1.56B
| $20.6M | 0.01% |
1,130,243
+10,959
| +1% | +$226K |
|
1205
Arrowhead Research
ARWR
$12.4B
| $20.5M | 0.01% |
505,635
-25,138
| -5% | -$833K |
|
1206
First Bancorp
FBNC
$2.7B
| $20.5M | 0.01% |
478,029
-12,262
| -3% | -$537K |
|
1207
Newell Brands
NWL
$2.63B
| $20.5M | 0.01% |
1,565,573
-963,532
| -38% | -$13.2M |
|
1208
Dr. Reddy's Laboratories
RDY
$10.1B
| $20.5M | 0.01% |
1,978,000
+63,875
| +3% | +$689K |
|
1209
Healthcare Realty
HR
$7.03B
| $20.4M | 0.01% |
1,060,506
+126,369
| +14% | +$2.48M |
|
1210
Unilever
UL
$137B
| $20.4M | 0.01% |
359,652
-15,760
| -4% | -$843K |
|
1211
Certara
CERT
$1.18B
| $20.3M | 0.01% |
1,265,353
-100,895
| -7% | -$1.46M |
|
|
MRO
1212
DELISTED
Marathon Oil Corporation
MRO
| $20.3M | 0.01% |
750,986
-668,219
| -47% | -$19.4M |
|
1213
Sibanye-Stillwater
SBSW
$6.81B
| $20.3M | 0.01% |
1,905,967
+273,369
| +17% | +$2.78M |
|
1214
Integer Holdings
ITGR
$4.23B
| $20.3M | 0.01% |
296,735
-54,249
| -15% | -$3.55M |
|
1215
Columbia Research Enhanced Core ETF
RECS
$5.99B
| $20.2M | 0.01% |
890,379
-1,098,502
| -55% | -$25.2M |
|
1216
Vanguard World Funds Extended Duration ETF
EDV
$3.27B
| $20.2M | 0.01% |
243,132
+43,242
| +22% | +$3.64M |
|
1217
Ziff Davis
ZD
$2.01B
| $20.2M | 0.01% |
254,847
+31,664
| +14% | +$2.55M |
|
1218
Macerich
MAC
$7.26B
| $20.1M | 0.01% |
1,780,787
-185,659
| -9% | -$2.1M |
|
1219
AZZ Inc
AZZ
$4.54B
| $20M | 0.01% |
498,629
+14,716
| +3% | +$578K |
|
1220
Boot Barn
BOOT
$4.95B
| $20M | 0.01% |
320,130
-3,198
| -1% | -$192K |
|
1221
Empire State Realty Trust
ESRT
$848M
| $20M | 0.01% |
2,967,173
+594,755
| +25% | +$4.19M |
|
1222
Kinsale Capital Group
KNSL
$8.29B
| $20M | 0.01% |
76,458
-7,500
| -9% | -$2.16M |
|
1223
WisdomTree US SmallCap Dividend Fund
DES
$2.23B
| $19.9M | 0.01% |
699,092
-72,330
| -9% | -$2.08M |
|
1224
VictoryShares US 500 Volatility Wtd ETF
CFA
$547M
| $19.8M | 0.01% |
291,981
+143,704
| +97% | +$9.62M |
|
1225
iShares Convertible Bond ETF
ICVT
$7.44B
| $19.8M | 0.01% |
284,652
+5,283
| +2% | +$372K |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.